|
Oropharyngeal Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Association between oropharyngeal cancers with known HPV and p16 status and cervical intraepithelial neoplasia: a Danish population-based study.
|
30626248 |
2019 |
|
Oropharyngeal Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
The search included published studies which dealt with detection methods of HPV-related oral and oropharyngeal cancers and biomolecular studies, particularly regarding the compromising of p53 p16 and e-cadherins.
|
29460521 |
2019 |
|
Oropharyngeal Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Definitive radiochemotherapy or initial surgery for oropharyngeal cancer : To what extent can p16 expression be used in the decision process?
|
30877351 |
2019 |
|
Oropharyngeal Carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Patients with OPC with available p16 status and tobacco history were eligible.
|
30913305 |
2019 |
|
Oropharyngeal Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Our findings support the hypothesis that p16 has a similar prognostic role in both nonoropharyngeal and oropharyngeal cancer.
|
29878161 |
2018 |
|
Oropharyngeal Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Oropharynx cancer with significant p16 expression showed an increased overall survival and elevated T- and B-lymphocyte infiltration, which suggests a prognostic relevance of immune cell infiltration.
|
29493423 |
2018 |
|
Oropharyngeal Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Relationship Between p16 Expression and Prognosis in Patients with Oropharyngeal Cancer Undergoing Surgery.
|
29936482 |
2018 |
|
Oropharyngeal Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Evaluate the prognostic and predictive impact of HPV-associated p16-expression and assess the combined prognostic impact of p16 and smoking on altered fractionated radiotherapy (AFRT) for oropharyngeal cancer (OPC) within the frames of the update of the Meta-Analysis of Radiotherapy in Carcinomas of Head and neck (MARCH).
|
29100700 |
2018 |
|
Oropharyngeal Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Our study investigates the prevalence, prognostic, and clinicopathologic features of HPV-related oropharyngeal cancer in Northeast China and elucidates the involvement of p16 in the tumorigenesis and progression of OPSCC.
|
30310820 |
2018 |
|
Oropharyngeal Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
The HPV values for Iowa patients with oropharyngeal cancers (n = 824) were recoded based on modified guidelines that included p16 test results, and compared with the original guidelines.
|
29934978 |
2018 |
|
Oropharyngeal Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Clinical outcomes and prognostic factors in cisplatin versus cetuximab chemoradiation for locally advanced p16 positive oropharyngeal carcinoma.
|
29598954 |
2018 |
|
Oropharyngeal Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
HPV infection and P16 expression in oral and oropharyngeal cancer in Kazakhstan.
|
29344081 |
2018 |
|
Oropharyngeal Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
The study subset with OPC and known p16 status was mainly from Australasia, Western Europe, and North America.
|
27209505 |
2017 |
|
Oropharyngeal Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
HPV16 was searched in 255 LA-HNC formalin-fixed paraffin-embedded tumor tissues, 89 oropharyngeal cancers (OPCs), and 166 non-OPCs by DNA-PCR with 3 primer pairs. p16 was analyzed by immunohistochemistry in 235 patients.
|
27040135 |
2017 |
|
Oropharyngeal Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Immunohistochemistry for p16 is established as a surrogate marker of human papillomavirus (HPV) in oropharyngeal cancer. p16 expression in HNcSCC needs to be elucidated to determine its utility in predicting the primary site.
|
28663082 |
2017 |
|
Oropharyngeal Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Objectives We analyze the relationship between CD44, epidermal growth factor receptor (EGFR), and p16 expression in oral cavity and oropharyngeal cancers in a diverse population.
|
28397583 |
2017 |
|
Oropharyngeal Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
We sought to investigate the pathology and rates of HPV head and neck oropharyngeal cancer in Japan via p16 immunohistochemistry at 2 institutions in Japan.
|
27913709 |
2017 |
|
Oropharyngeal Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Patients with oropharyngeal carcinoma positive for human papillomavirus or p16 lived longer after locoregional failure compared with patents with oropharyngeal carcinoma negative for human papillomavirus or p16 (median survival, 36.5 vs 13.6 months; P = .007) but not after distant metastasis.
|
28542679 |
2017 |
|
Oropharyngeal Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
The pretreatment QOL/PS scores were correlated with outcome and p16 status in patients with oropharyngeal cancer (OPC).
|
27727066 |
2017 |
|
Oropharyngeal Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Tumor p16 status was evaluable in 182 patients with OPC enrolled in the IMCL-9815 study; 41% were p16 positive.
|
26712222 |
2016 |
|
Oropharyngeal Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
No benefit for regional control and survival by planned neck dissection in primary irradiated oropharyngeal cancer irrespective of p16 expression.
|
26059208 |
2016 |
|
Oropharyngeal Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Impact of p16 expression in oropharyngeal cancer in the postoperative setting: the necessity of re-evaluating traditional risk stratification.
|
27474125 |
2016 |
|
Oropharyngeal Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
The diagnosis of HPV-related oropharyngeal cancer in clinical practice is based on p16 immunohistochemistry and PCR detection of viral DNA (HPV-PCR).
|
25687724 |
2015 |
|
Oropharyngeal Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Population-based p16 and HPV positivity rates in oropharyngeal cancer in Southeast Scotland.
|
26152733 |
2015 |
|
Oropharyngeal Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
We performed immunohistochemistry for the p16 protein, in situ hybridization for human papillomavirus-deoxyribonucleic acid and polymerase chain reaction for the human papillomavirus-deoxyribonucleic acid oncogene E6 in oropharyngeal carcinoma in Japanese patients.
|
26056326 |
2015 |